P38-α MAPK-IN-8
P38-α MAPK-IN-8 (Compound 13) is a lipophilic cationic derivative. p38-α MAPK-IN-8 is cytotoxic to various tumor cells, and can induce cell cycle arrest, apoptosis, increase reactive oxygen species (ROS) production, and induce mitochondrial membrane potential depolarization. The antitumor activity of p38-α MAPK-IN-8 may be related to p38α MAPK pathway, which can be used in the study of cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; p38 MAPK; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
C[C@]12CC[C@]3([C@@](CC=C4C[C@@H](OC(CCC[P+](C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)=O)CC[C@@]43C)([C@@]1(C[C@]8([H])O[C@]9(CC[C@@H](C)CO9)[C@@H](C)[C@@]82[H])[H])[H])[H].[Br-]
Molecular Formula
C49H62BrO4P
Molecular Weight
825.89
References & Citations
[1]An RF, et al. Design, synthesis and cytotoxic activity of novel lipophilic cationic derivatives of diosgenin and sarsasapogenin. Bioorg Med Chem Lett. 2025 Jan 6;119:130094.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400043-100 1x 100 µL
P21 / WAF1 (WA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740994-100 1x 100 µL
TNF alpha (J2D10), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940096-100 1x 100 µL
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040665-500 1x 500 µL
Smooth Muscle Actin (1A4), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details